HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andres Forero-Torres Selected Research

ocaratuzumab

1/2015Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphoma.
3/2012Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andres Forero-Torres Research Topics

Disease

31Neoplasms (Cancer)
11/2021 - 08/2005
29Breast Neoplasms (Breast Cancer)
06/2022 - 08/2010
17Hodgkin Disease (Hodgkin's Disease)
01/2022 - 07/2009
10Triple Negative Breast Neoplasms
12/2021 - 07/2012
9Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2022 - 12/2007
7Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2018 - 07/2009
6Lymphoma (Lymphomas)
10/2014 - 12/2007
5Pathologic Complete Response
12/2021 - 01/2020
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 03/2011
4Fatigue
05/2021 - 03/2012
4Hematologic Neoplasms (Hematological Malignancy)
01/2017 - 01/2012
3Neutropenia
05/2021 - 08/2017
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2018 - 01/2012
2Neoplasm Metastasis (Metastasis)
09/2021 - 01/2019
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 09/2012
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2018 - 12/2013
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 02/2010
2Nausea
01/2015 - 12/2013
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2015 - 03/2012
2Peripheral Nervous System Diseases (PNS Diseases)
03/2014 - 08/2012
1Brain Neoplasms (Brain Tumor)
06/2022
1Left Ventricular Dysfunction
02/2022
1Cardiotoxicity
02/2022
1Residual Neoplasm
11/2021
1Hyperglycemia
10/2021
1Premature Menopause
08/2021
1Infertility (Sterility)
08/2021
1Amenorrhea
08/2021
1Exanthema (Rash)
05/2021
1Leukopenia
05/2021
1Diarrhea
05/2021

Drug/Important Bio-Agent (IBA)

18Brentuximab VedotinIBA
01/2022 - 11/2010
14Monoclonal AntibodiesIBA
05/2021 - 08/2007
12Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 06/2012
8Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 06/2012
7Trastuzumab (Herceptin)FDA Link
02/2022 - 07/2015
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2021 - 09/2012
6Hormones (Hormone)IBA
12/2021 - 08/2018
6Rituximab (Mabthera)FDA Link
01/2019 - 01/2008
6dacetuzumabIBA
01/2015 - 09/2009
5Bendamustine HydrochlorideFDA Link
09/2022 - 12/2007
5ErbB Receptors (EGF Receptor)IBA
06/2022 - 07/2012
5Ado-Trastuzumab EmtansineIBA
02/2022 - 09/2015
4Dacarbazine (DIC)FDA LinkGeneric
01/2022 - 01/2019
4Vinblastine (Vinblastine Sulfate)FDA Link
01/2022 - 01/2019
4Pharmaceutical PreparationsIBA
10/2021 - 08/2012
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2020 - 06/2016
4Prednisone (Sone)FDA LinkGeneric
01/2019 - 09/2012
4Vincristine (Oncovin)FDA LinkGeneric
01/2019 - 09/2012
4tigatuzumabIBA
06/2015 - 02/2010
3Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 01/2019
3Biomarkers (Surrogate Marker)IBA
10/2021 - 08/2017
3Immunoconjugates (Immunoconjugate)IBA
05/2021 - 12/2014
3Lapatinib (GW572016)FDA Link
05/2021 - 07/2015
3Carboplatin (JM8)FDA LinkGeneric
01/2019 - 07/2012
3GemcitabineFDA Link
01/2018 - 02/2013
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
06/2015 - 02/2010
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021 - 01/2021
2pertuzumabIBA
11/2021 - 05/2021
2tucatinibIBA
11/2021 - 01/2020
2Fulvestrant (Faslodex)FDA Link
01/2021 - 06/2016
2pembrolizumabIBA
11/2020 - 01/2020
2Letrozole (Femara)FDA LinkGeneric
01/2020 - 08/2010
2Bevacizumab (Avastin)FDA Link
01/2020 - 08/2010
2Tyrosine Kinase InhibitorsIBA
01/2020 - 07/2015
2Progesterone Receptors (Progesterone Receptor)IBA
01/2020 - 08/2010
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 08/2010
2IfosfamideFDA LinkGeneric
01/2019 - 01/2015
2itacitinibIBA
01/2019 - 01/2018
2Alanine Transaminase (SGPT)IBA
01/2019 - 01/2019
2Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2005
2Etoposide (VP 16)FDA LinkGeneric
01/2019 - 01/2015
2Death Domain ReceptorsIBA
01/2018 - 08/2007
2ocaratuzumabIBA
01/2015 - 03/2012
2ibritumomab tiuxetan (Zevalin)FDA Link
06/2013 - 09/2012
1ofatumumabFDA Link
09/2022
1olaparibIBA
12/2021
1durvalumabIBA
12/2021
1Immune Checkpoint InhibitorsIBA
12/2021
1ganitumabIBA
10/2021
1Metformin (Glucophage)FDA LinkGeneric
10/2021
1Hemoglobins (Hemoglobin)IBA
10/2021
1Capecitabine (Xeloda)FDA Link
05/2021
1glembatumumab vedotinIBA
05/2021
1Adenosine Triphosphate (ATP)IBA
05/2021
1AlpelisibIBA
01/2021
1ribociclibIBA
01/2021
1NVP-BKM120IBA
01/2021
1veliparibIBA
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2020

Therapy/Procedure

23Therapeutics
11/2021 - 08/2007
14Drug Therapy (Chemotherapy)
11/2021 - 08/2007
9Neoadjuvant Therapy
02/2022 - 09/2015
3Immunotherapy
11/2020 - 08/2012
3Stem Cell Transplantation
01/2018 - 01/2012
2Salvage Therapy
01/2020 - 01/2015
2Adjuvant Chemotherapy
01/2020 - 12/2011
2Radioimmunotherapy
06/2013 - 08/2005
1Investigational Therapies (Experimental Therapy)
11/2021
1Drug Tapering
12/2020